PNW
45
-4
MNST
59
3
FLR
38
2
BBY
51
-2
IVZ
48
5
PX
62
14
AVGO
40
-14
VLO
35
2
SE
44
-13
PNC
45
4
NWL
28
-4
CINF
53
6
CL
77
2
HSY
53
8
HBI
45
8
SPG
61
8
BEN
48
4
PH
64
2
LNC
48
2
VZ
29
5
PNW
45
-4
MNST
59
3
FLR
38
2
BBY
51
-2
IVZ
48
5
PX
62
14
AVGO
40
-14
VLO
35
2
SE
44
-13
PNC
45
4
NWL
28
-4
CINF
53
6
CL
77
2
HSY
53
8
HBI
45
8
SPG
61
8
BEN
48
4
PH
64
2
LNC
48
2
VZ
29
5
Financhill
Back

Cytokinetics Stock Price Chart

Jeff Bezos's Plan Exposed

And for investors who get in now profits could be massive - click here for full story.
Buy
52

CYTK
Cytokinetics

Last Price:
52.86
Seasonality Move:
5.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon's New AI Device is About to Shock the World

Click here to see the details because a lot of people could get rich from this new invention.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

Cytokinetics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 53.08 Buy
20-day SMA: 51.6 Buy
50-day SMA: 58.73 Sell
200-day SMA: 55.73 Sell
8-day EMA: 53.02 Buy
20-day EMA: 53.6 Buy
50-day EMA: 57.71 Sell
200-day EMA: 56.9 Sell

Cytokinetics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.4 Sell
Relative Strength Index (14 RSI): 47.99 Sell
Chaikin Money Flow: 69998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.06 - 56.58) Buy
Bollinger Bands (100): (56.38 - 74.98) Sell

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cytokinetics Stock

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 53.85 while CYTK 8-day simple moving average is 53.08, which is a Buy signal.
  • The stock price of CYTK is 53.85 while Cytokinetics 20-day SMA is 51.60, which makes it a Buy.
  • Cytokinetics 50-day simple moving average is 58.73 while CYTK share price is 53.85, making it a Sell technically.
  • CYTK stock price is 53.85 and Cytokinetics 200-day simple moving average is 55.73, creating a Sell signal.

CYTK Technical Analysis vs Fundamental Analysis

Buy
52
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Buy
    The current Cytokinetics [CYTK] share price is $53.85. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.

Cytokinetics Stock Info

Market Cap:
5.65B
Price in USD:
53.85
Share Volume:
909.98K

Cytokinetics 52-Week Range

52-Week High:
110.25
52-Week Low:
25.98
Buy
52
Cytokinetics (CYTK) is a Buy

Cytokinetics Share Price Forecast

  • What is the Cytokinetics stock price today?
    The Cytokinetics stock price is 53.85 USD today.
  • Will CYTK stock go up or go down?
    Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
  • Is Cytokinetics overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is not overvalued.

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 53.85 while CYTK 8-day exponential moving average is 53.02, which is a Buy signal.
  • The stock price of CYTK is 53.85 while Cytokinetics 20-day EMA is 53.60, which makes it a Buy.
  • Cytokinetics 50-day exponential moving average is 57.71 while CYTK share price is 53.85, making it a Sell technically.
  • CYTK stock price is 53.85 and Cytokinetics 200-day simple moving average is 56.90, creating a Sell signal.

Fundamental Analysis of Cytokinetics

Is Cytokinetics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.08 per share.

Technical Analysis of Cytokinetics

Should I short Cytokinetics stock?

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.